retatrutide trial results today Looking forward to when #retatrutide's Phase 3 will become available. There are are 4 planned TRIUMPH trials investigating retatrutide's efficacy in treating obesity and its complications: #type2diabetes #cardiovascular disease Retatrutide for weight loss: Study

If approved, this could mark a major shiftbringing effective obesity treatment to millions more who prefer oral therapies

Evidence now warrants a focus on the beta cell itself and how to avoid its dysfunction, which is putatively caused by cytokine-driven inflammation and other stress factors, leading to low insulin-secretory capacity, autoantigen presentation and immune-mediated destruction

CDPHP has teamed up with GTM to offer comprehensive health benefits to clients of GTMs Professional Employer Organization (PEO)

Recognize gastroparesis symptoms early to prevent complications

If you have been avoiding GLP-1 weight loss drugs because of a fear of needles, you are not alone

The FDA significantly increased its compliance activity surrounding advertising for compounded drugs in 2025, and recent remarks from an FDA official highlighted the agencys concerns about claims that state or imply the equivalence of compounded drugs to approved drugs.